close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar186056Point77
Implied share price

Buy Undervalued by 237672.2%

5% margin of safety What's this?

EV / Revenue
Use Average
ABII
Abraxis Bioscience, Inc.
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
SNY
Sanofi SA (ADR)
Change
AMGN
Amgen, Inc.
Change
20968.4 8.25 27840.41 14.19 2.04 7.31
All amounts in millions
from last financial year
         
Implied Share Price $186056.77 $47051.42 $155685.39 $528777.69 $514800.22
Market Cap 3,166 1,229,412 154,396 124,965 123,715
Net Debt -203 20 4,504 6,333 12,727
Enterprise Value (EV) 2,963 1,229,432 158,900 67,838 136,442
Revenue 359 44 11,201 33,306 18,676
Balance Sheet          
Total Assets 1,068 58 22,496 96,055 66,125
Total Liabilities 225 56 11,127 39,151 44,029
Shareholders Equity 842 2 11,369 56,904 22,096.0

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.